DADRA
  Pharmaceuticals

 



   

Chemical name

1, 4-Benzenediol.

Category

Depigmenting agent, bleeching agent.

Mechanism of action

Topical application of Hydroquinone produces a reversible depigmentation of the skin by inhibition of the enzymatic oxidation of tyrosine to 3, 4-dihydroxyophenyl alanine (dopa) and suppression of other melanocyte metabolic processes.

Indications

For the gradual bleaching of hyperpigmented skin conditions such as chloasma, melasma, freckles, senile lentigines and other unwanted areas of melanin hyperpigmentation.

Precautions to consider

Hydroquinone should not be applied to abraded or sunburnt skin. It should not be used to bleach eyelashes or eyebrows and contact with the eyes should be avoided as it may produce staining and corneal opacities. High concentrations or prolonged use may produce hyperpigmentation especially on areas of skin exposed to sunlight.

Pregnancy

Category - C

Breast - feeding

It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.

Drug interactions

None.

Side / Adverse effects

No systemic adverse reactions have been reported. Occasional hypersensitivity (localized contact dermatitis) may occur.

Administration and dosage

Hydroquinone should be applied twice daily only to intact skin which should be protected from sunlight to reduce repigmentation.

How supplied

Hydroquinone 4% Creams are supplied in 30 g tube.

Storage

Store below 30° C, protect from freezing.
Keep out of reach of children.

References

1 - PDR 55 edition Volume II page: 1534
2 - Martindale 32nd edition Volume I page: 1083

   
 

 Home | About Us | Products | R&D | Import/Export | Contact Us
© 2006 All Rights Reserved.